Subscribe to RSS

DOI: 10.1055/s-0043-1774295
Clinical-Epidemiological Characterization of Human anal Papilloma Virus Infection Coloproctology Unit. Central University Hospital Dr. “Antonio Maria Pineda”
Authors

Abstract
Human papillomavirus (HPV) infection is one of the most common sexually transmitted viral diseases. A descriptive cross-sectional study was conducted with the purpose of clinically and epidemiologically characterizing anal HPV infection in patients who attended the Benign Orificial Pathology Consultation of the Coloproctological Unit at the Dr. “Antonio María Pineda” Central University Hospital, during the period March 2022 - February 2023, by selecting 288 patients whose average age was 47.09 ± 14.61 years, being the 41-50 years old group (29.17%) and the 51-60 years old group (19.44%) the most affected groups by pathologies of the anal region, with a predominance of male (54.17%). The sociodemographic characteristics with the highest frequency included married (48.61%) and single (47.22%); secondary level of education (44.44%) and traders (18.05%) and housewives (15, 28%) as predominant occupations. The risk factors were represented by onset of sexual intercourse between 16-20 years of age (65.28%), heterosexuality (91.67%), 22.22% reported having anal sex and 5.56% oral sex. Likewise, 5.56% were reported with a history of genital HPV and 4.17% were HIV positive. In addition, 48.61% stated not to use condoms. The initial clinical diagnosis included hemorrhoidal disease (30.55%), anal fistula (25%) and anal fissure (18.05%), and one patient (1.39%) with anal HPV infection. Anal cytology results showed 8.33% flat epithelial cells with cytopathic changes suggestive of HPV infection and 1.39% squamous cells with cytopathic changes suggestive of HPV infection: 50% mild inflammatory negative for malignancy and 33.33% flat epithelial cells without atypia. In conclusion, the anal cytology investigation should continue to determine the actual frequency of anal HPV infection.
Keywords
Human Papilloma Virus - anal infection - epidemiological characteristics - clinical characteristics - anal cytologyPublication History
Received: 14 April 2023
Accepted: 14 August 2023
Article published online:
21 September 2023
© 2023. Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Bruni L, Albero G, Serrano B. et al. Virus del papiloma humano y enfermedades relacionadas en el mundo. Centro de información ICO/IARC sobre VPH y cáncer (HPV Information Centre). 2019 . Available at: https://www.hpvcentre.net/statistics/reports/XWX.pdf (Consulta: 2022, noviembre 03)
- 2 Caraballo L, Salazar N, Lorenzo C, González M, Carrillo C, Hernández D. Infección por virus de papiloma humano: asociación entre infección genital y anal-perianal. Rev Obstet Ginecol Venez 2010; 70 (04) 254-264
- 3 Carballo S. Conductas sexuales de riesgo y Creencias en salud en jóvenes universitarios. Trabajo de fin de grado para titulación: Grado de Enfermería. Universidad de La Laguna. Tenerife, España; 2017
- 4 Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis 2014; 41 (11) 660-664
- 5 Choi Y, Loutfy M, Remis RS. et al. HPV genotyping and risk factors for anal high-risk HPV infection in men who have sex with men from Toronto, Canada. Sci Rep 2021; 11 (01) 4779
- 6 de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 2017; 141 (04) 664-670
- 7 De Villiers E. Cruce de caminos en la clasificación de los virus del papiloma. Virología 2013; 445 (1–2): 2-10
- 8 Doorbar J, Quint W, Banks L. et al. The biology and life-cycle of human papillomaviruses. Vaccine 2012; 30 (30, Suppl 5) F55-F70
- 9 Egawa N, Doorbar J. The low-risk papillomaviruses. Virus Res 2017; 231: 119-127
- 10 Egawa N, Egawa K, Griffin H, Doorbar J. Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia. Viruses 2015; 7 (07) 3863-3890
- 11 Hirsch B, McGowan J, Fine S. et al. Screening for anal dysplasia and cancer in adults with HIV. Baltimore (MD): Johns Hopkins University; 2022. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK556472/
- 12 International Agency for Research on Cancer. Working group on the evaluation of carcinogenic risks to humans. IARC 2007; 90: 1-636
- 13 Kombe Kombe AJ, Li B, Zahid A. et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front Public Health 2021; 8: 552028
- 14 Latan J, Fernandes A, López M, Fermín M, Correnti M. Detección de la infección por virus de papiloma humano en ano en pacientes con lesiones en cuello uterino. Rev Obstet Ginecol Venez 2017; 77 (02) 92-99
- 15 LeConte B, Szaniszlo P, Fennewald S. et al. Diferencias en el genoma viral entre el cáncer cervical y orofaríngeo positivo para el VPH. PLoS Uno 2018; 13 (08) e0203403
- 16 Lin C, Franceschi S, Clifford GM. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. Lancet Infect Dis 2018; 18 (02) 198-206
- 17 Lizano M, Carrillo A, Contreras A. Infección por virus del Papiloma Humano: Epidemiología, Historia Natural y Carcinogénesis. Cancerologia 2009; 4: 205-216
- 18 Llorente F, Rengifo C. Prevalencia de infección anal por el virus del papiloma humano en el Hospital “Comandante Manuel Fajardo”. Rev Cuba Cir 2017; 56 (01) 235 (Consulta: 2022, mayo 13)
- 19 Marra E, Lin C, Clifford G. Prevalence of type-specific anal human papillomavirus among men, according to sexual preference and HIV status: a systematic review of the literature and meta-analysis. J Infect Dis 2019; 219 (04) 590-598
- 20 Membrilla-Fernández E, Parés D, Alameda F. et al. [Anal intraepithelial neoplasia: application of a diagnostic protocol in risk patients using anal cytology]. Cir Esp 2009; 85 (06) 365-370
- 21 Mühr L, Eklund C, Dillner J. Hacia la calidad y el orden en la investigación del virus del papiloma humano. Virología 2018; 519: 74-76
- 22 Mujica M, Cabré S, Zeman P, Lira N. Manual para la Elaboración y Presentación del Trabajo Especial de Grado, Trabajo de Grado y Tesis Doctoral del Decanato de Ciencias de la Salud. Consejo Universitario Sesión N° 2127. Gaceta N° 126. 1° Edición. Universidad Centroccidental “Lisandro Alvarado”; 2011
- 23 Ortiz P, Guiot H, Colon V, Muñoz C, Medina D, Carrión J, Rodríguez Y. et al. Virus del papiloma humano y lesiones anales intraepiteliales. Galenus 2018;63(02):
- 24 Padilla L. Cribado de neoplasia intraepitelial anal en diferentes grupos poblacionales de riesgo estudio epidemiológico, clínico y molecular. Tesis Doctoral. Universidad de Málaga; 2017. . Disponible en: http://orcid.org/0000-0003-3583-8439 . (Consulta: 2022, mayo 10)
- 25 Posada D, Tamayo L, Valencia M, Vásquez G. Infección por el virus del papiloma humano de alto riesgo y factores asociados en canal anal de pacientes con VIH en Medellín, 2017–2018. Rev Saude Publica 2020; 54: 93
- 26 Posso H, León L, Allen B. et al. Prevalencia e incidencia de la infección por el virus del papiloma humano anal en hombres mexicanos: Necesidad de políticas universales de prevención. Salud Publica Mex 2018; 60 (06) 645-652
- 27 Poynten IM, Machalek D, Templeton D. et al. Comparison of age-specific patterns of sexual behaviour and anal HPV prevalence in homosexual men with patterns in women. Sex Transm Infect 2016; 92 (03) 228-231
- 28 Salit I, Lytwyn A, Raboud J. et al. The role of cytology (Pap smears) and human papillomavirus tests in the detection of anal cancer. AIDS 2010; 24 (09) 1307-1313
- 29 Sánchez D, Guerrero M, Rubio J, Ángel E, Rey G, Díaz L. Prevalencia de Infección por Virus del Papiloma Humano de alto riesgo y citología anormal en la zona de Transformación Anal en mujeres con displasia cervical. Bogotá, Colombia, 2017–2019. Rev Colomb Obstet Ginecol 2020; 71 (04) 345-355
- 30 Schiffman M, Doorbar J, Wentzensen N. et al. Infección por el virus del papiloma humano cancerígeno. Nat Rev Dis Primers 2016; 2: 16086
- 31 Sendagorta E, Burgos J, Rodríguez M. Infecciones genitales por el virus del papiloma humano. Enferm Infecc Microbiol Clin 2019; 37 (05) 324-334
- 32 Shiojiri D, Mizushima D, Takano M. et al. Anal human papillomavirus infection and its relationship with abnormal anal cytology among MSM with or without HIV infection in Japan. Sci Rep 2021; 11 (01) 19257
- 33 Stier EA, Sebring MC, Mendez AE, Ba FS, Trimble DD, Chiao EY. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review. Am J Obstet Gynecol 2015; 213 (03) 278-309
- 34 Sullcahuaman-Allende Y, Castro-Mujica MdelC, Mejía Farro R. et al. Características sociodemográficas de mujeres peruanas con virus papiloma humano detectado por PCR-RFLP. Rev Peru Med Exp Salud Publica 2015; 32 (03) 509-514
- 35 Tafani R, Chiesa G, Caminati R, Gaspio N. Factores de Riesgo y Determinantes de la Salud. Rev Salud Publica (Bogota) 2013; 4 (XVII): 53-68
- 36 Taylor S, Bunge E, Bakker M, Castellsagué X. The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature. BMC Infect Dis 2016; 16: 293
- 37 Uribe A, Castellanos J, Cabán M. Conductas sexuales de riesgo y comunicación sobre sexualidad entre padres e hijos universitarios. Rev. Psicología: (Universidad de Antioquia) 2016; 8 (02) 27-48
- 38 Uribe J, Riaño M, Bonilla N, Carrillo S, Hernández Y, Bahamón M. Percepción de autoeficacia vs. rechazo del uso del condón en las prácticas sexuales de mujeres y hombres jóvenes. Psicogente 2017; 20 (37) 25-35